Status:
WITHDRAWN
Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer
Lead Sponsor:
Odense University Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
Prostate cancer is currently the leading newly diagnosed cancer in the industrialized world. Treatment of prostate cancer is highly dependent on the stage of the disease. Current methods for staging o...
Detailed Description
1. Introduction. Cancer of the prostate (PCa) is currently the leading newly diagnosed cancer and the second most common cause of cancer deaths among men in the industrialized world . In Denmark alone...
Eligibility Criteria
Inclusion
- Newly diagnosed, histologically verified PCa and
- Written consent and
- Planned extended lymph node dissection and
- PSA ≥ 20 ng/mL and/or
- Gleason score \> 6 and/or
- cT-stage ≥ cT2c
Exclusion
- Withdrawal of consent or
- Other active malign disease
Key Trial Info
Start Date :
November 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02232672
Start Date
November 1 2016
End Date
August 1 2017
Last Update
October 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospiatal
Odense, Denmark, 5000